Last reviewed · How we verify
Osteoporosis
Approved treatments
- Tricalcium Phosphate
- Risedronate · Toronto Rehabilitation Institute
- Prepopik · Baxter
- ELDECALCITOL · Chugai Pharmaceutical Co., Ltd
- Infuvite Adult · Novartis
- Bisphonal · Astellas Pharma
- Vitamin D3
- CALCIUM LACTATE
- Drisdol · Esjay Pharma
- Neridronate
Neridronate works by inhibiting the enzyme Farnesyl pyrophosphate synthase, which plays a crucial role in bone resorption. - Calciferol · Department of Medical Services Ministry of Public Health of Thailand
- Trimagnesium Dicitrate
- BUTEDRONIC ACID
Butedronic acid works by inhibiting osteoclast activity, which are cells responsible for breaking down bone tissue. - phytomenadione · Instituto Mexicano del Seguro Social
- Tymlos · Radius
Tymlos works by mimicking the action of parathyroid hormone to stimulate bone growth and increase bone density. - Prolia · Amgen
Prolia works by blocking a protein that breaks down bone. - CALCIUM CITRATE
- Zometa · Novartis
Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity. - Calcium Gluconate
Calcium gluconate increases serum ionized calcium levels when administered intravenously. - Zometa · University of Arkansas
- Neridronate · Ente Ospedaliero Ospedali Galliera
- Zoledronate · Children's Hospital Medical Center, Cincinnati
- Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
- Minodronate · Peking University Third Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape: